Abortion access is limited
Beyond inducing weight loss, these treatments have demonstrated benefits on obesity-related complications, including neuropsychiatric and substance use disorders, peripheral vascular disease, arthritis, MASLD, hypertension and renal disorders, positioning them as a central focus in current obesity research [3]
However, if semaglutide causes nausea or vomiting, it may reduce the absorption of oral contraceptives in some casesthough this is uncommon
The age-standardised incidence rate of BC among Bahraini women was 58.2 per 100,000 in 2000, 44.4 per 100,000 in 2010 [31], and 44.2 per 100,000 in 2020 [32]
His approach with Semaglutide GLP-1 therapy is designed to target the underlying causes of weight gain by improving metabolism and appetite regulation
Pirruccello-Straub, M